Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

eg solutions Chief trades in 1.21m shares

Wed, 02nd Jul 2014 16:11

Elizabeth Gooch, the acting Chief Executive Officer of eg solutions has traded in a total of 1.21m shares at 52p each, the software company said on Wednesday. Of these, 120,000 were acquired by the company's former Chairman, Rodney Baker-Bates, and a further 60,000 by Mark Brady, a non-executive director. Following the £629.200 transaction, Gooch now holds 5.3m shares, equal to 32.2% of the issued share capital of the AIM-listed firm. The disposal comes one month after the group posted an upbeat trading statement, in which it said it expected revenues for the first half of the year to be ahead of the same period the prior year, and that its financial performance for the full year will be ahead of its own expectations. Top Director BuysGlaxoSmithKline (GSK) Director name: Sir Sir Christopher GentAmount purchased: 3,989 @ 1,564.00p Value: £62,388GlaxoSmithKline (GSK) Director name: Sir Sir Deryck MaughanAmount purchased: 2,189 @ 1,567.92p Value: £34,322GlaxoSmithKline (GSK) Director name: Dr Daniel (Dan) PodolskyAmount purchased: 1,641 @ 1,567.92p Value: £25,730Development Securities (DSC) Director name: Mr Barry BennettAmount purchased: 15,000 @ 215.55p Value: £32,332GlaxoSmithKline (GSK) Director name: Ms Lynn ElsenhansAmount purchased: 1,155 @ 1,567.92p Value: £18,109GlaxoSmithKline (GSK) Director name: Mr Dr Stephanie BurnsAmount purchased: 868 @ 1,567.92p Value: £13,610GlaxoSmithKline (GSK) Director name: Ms Judy LewentAmount purchased: 736 @ 1,567.92p Value: £11,540European Investment Trust (EUT) Director name: Dr. Michael WoodwardAmount purchased: 1,911 @ 779.97p Value: £14,905GlaxoSmithKline (GSK) Director name: Ms Jing UlrichAmount purchased: 547 @ 1,567.92p Value: £8,577Top Director SellsLiontrust Asset Management (LIO) Director name: Mr John Stephen IonsAmount sold: 900,000 @ 240.00p Value: £2,160,000Liontrust Asset Management (LIO) Director name: Mr Adrian John Reginald CollinsAmount sold: 500,000 @ 240.00p Value: £1,200,000EG Solutions (EGS) Director name: Ms Elizabeth GoochAmount sold: 1,210,000 @ 52.00p Value: £629,200Liontrust Asset Management (LIO) Director name: Mr Vinay Kumar AbrolAmount sold: 100,000 @ 240.00p Value: £240,000Vectura Group (VEC) Director name: Mr John R. BrownAmount sold: 159,100 @ 133.00p Value: £211,603Stagecoach Group (SGC) Director name: Mr Brian SouterAmount sold: 54,758 @ 376.70p Value: £206,273Vectura Group (VEC) Director name: Dr Trevor PhillipsAmount sold: 109,500 @ 133.00p Value: £145,635Stagecoach Group (SGC) Director name: Mr Martin GriffithsAmount sold: 34,437 @ 376.70p Value: £129,724Stagecoach Group (SGC) Director name: Mr Ross PatersonAmount sold: 12,760 @ 376.70p Value: £48,067British Assets Trust (BSET) Director name: Miss Lynn RuddickAmount sold: 11,180 @ 135.50p Value: £15,149NR
More News
18 Dec 2020 08:12

Hikma rallies as it launches generic version of Glaxo asthma treatment

(Sharecast News) - Hikma Pharmaceuticals shares rallied after the company said it had received approval from the US Food and Drug Administration and launched its generic version of GlaxoSmithKline's asthma treatment, Advair Diskus.

Read more
17 Dec 2020 18:10

Hikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus

Hikma Pharmaceuticals Gets US FDA Approval For Generic Advair Diskus

Read more
4 Dec 2020 13:05

IN BRIEF: Tissue Regenix Adds Former Vectura COO To Board

IN BRIEF: Tissue Regenix Adds Former Vectura COO To Board

Read more
30 Nov 2020 09:53

Vectura Inks Agreement To Support Kinaset Therapeutics For Asthma Drug

Vectura Inks Agreement To Support Kinaset Therapeutics For Asthma Drug

Read more
30 Nov 2020 08:06

Vectura signs asthma treatment deal with Kinaset

(Sharecast News) - Vectura has signed a global licence and development deal with Kinaset Therapeutics of the US for the development and commercialisation of the VR588 pan-JAK asthma treatment.

Read more
20 Nov 2020 08:34

Court denies GSK appeal in Vectura intellectual property dispute

(Sharecast News) - Inhalation-focussed contract design and manufacture organisation Vectura Group announced on Friday that the United States Court of Appeals for the Federal Circuit has denied GlaxoSmithKline's (GSK) motions for judgment as a matter of law, a new trial on infringement, and for a new trial on damages in litigation concerning Vectura's US patent 8303991.

Read more
19 Nov 2020 20:25

IN BRIEF: Vectura Notes US Court Denying GSK's Motions For New Trials

IN BRIEF: Vectura Notes US Court Denying GSK's Motions For New Trials

Read more
28 Sep 2020 15:53

UK EXECUTIVE CHANGE SUMMARY: Tracsis Appoints New Finance Chief

UK EXECUTIVE CHANGE SUMMARY: Tracsis Appoints New Finance Chief

Read more
22 Sep 2020 19:34

IN BRIEF: Vectura Notes Hikma's Advair US Regulatory Setback

IN BRIEF: Vectura Notes Hikma's Advair US Regulatory Setback

Read more
15 Sep 2020 17:22

Vectura Revenue Slips But Swings To First Half Profit

Vectura Revenue Slips But Swings To First Half Profit

Read more
14 Sep 2020 17:21

UK TRADING UPDATE SUMMARY: Henry Boot Unit In Voluntary Liquidation

UK TRADING UPDATE SUMMARY: Henry Boot Unit In Voluntary Liquidation

Read more
2 Sep 2020 19:36

TOP NEWS: ITV Bumped From FTSE 100 For B&M European Value Retail

TOP NEWS: ITV Bumped From FTSE 100 For B&M European Value Retail

Read more
7 Jul 2020 16:35

UK TRADING UPDATE SUMMARY: Retailer Sosandar In Quarterly Revenue Jump

UK TRADING UPDATE SUMMARY: Retailer Sosandar In Quarterly Revenue Jump

Read more
9 Jun 2020 12:04

DIRECTOR DEALINGS: Vectura Group Non-Exec Matthews Buys First Shares

DIRECTOR DEALINGS: Vectura Group Non-Exec Matthews Buys First Shares

Read more
8 Jun 2020 15:00

Vectura Inks Deal With Aerami To Develop Inhaled Imatinib

Vectura Inks Deal With Aerami To Develop Inhaled Imatinib

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.